The best alternatives to ProjectionLab are Causal, Graphy, and finimize. If these 3 options don't work for you, we've listed over 10 alternatives below.
What do you think of ProjectionLab?
Notion— Get over $6,000 worth of Notion + unlimited AI, for free
Causal lets you build financial models effortlessly, connect them directly to your data, and share them with interactive dashboards and beautiful visuals. Run scenarios, compare versions, manage cash and burn, and prepare for fundraising.
At Graphy we’re on a mission to give everyone data superpowers, our goal is to build the easiest to use and most collaborative data visualization platform on the market.
Managing money can be complicated. Track all of your accounts in one place, collaborate with a partner, and create a long term plan to achieve your goals. Get personalized advice along the way.
Never Miss a Beat. Smarter & sharper in 3 mins. Business news for future business newsmakers. Lumio Spotlight is our weekly straight-talking email covering the business & market news impacting your finances.
Combine is a mobile application that lets you connect all your bank accounts into one feed and see aggregated statistics, spending insights and regular payments across all your account in multiple countries simultaneously.
Spend Less is a free Chrome extension that detects when a website is trying to sell something, delivers a beautiful message to help users think intentionally about the purchase, and sends the user somewhere else if they realize they just fell for marketing.
We created an alternative way to save that not only pays 5% interest but supports growing businesses across the country. We do this through our proprietary, SEC qualified, $10 Worthy bonds. Bond proceeds are invested in secured, asset-backed loans to American companies. Bonds can also be bought via spare change round-ups for painless savings!
Glade is a fully integrated platform for enterprises to do financial planning, reporting, and analytics. We have 2 signed LOIs with companies like Cytek, a billion-dollar public biotech enterprise, who will use us to forecast revenue and plan headcount.